Summary
American-led investment in AIDS programs has significantly reduced deaths from the disease and provided vital medicines to vulnerable populations. However, the recent sudden withdrawal of U.S. funding could reverse these gains, potentially leading to millions of new HIV infections and deaths by 2029.
Key Facts
- U.S. funding for AIDS programs has been crucial in lowering AIDS-related deaths to the lowest in over 30 years.
- The sudden cut in U.S. aid has disrupted health services, affecting clinics and supply chains.
- If not replaced, the funding cuts could cause over 4 million AIDS-related deaths and 6 million new HIV infections by 2029.
- The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has supported HIV testing and treatment for millions of people.
- PEPFAR provided almost the entire budget for HIV prevention medicines in Nigeria.
- Most new HIV infections are occurring in sub-Saharan Africa, where funding gaps remain.
- The U.S. funding also supported HIV surveillance, which is now at risk without American aid.
- A new drug that prevents HIV was approved by the U.S. FDA, offering hope for future prevention efforts.
